Comparison of Gastric Cancer Survival Following R0 Resection in the United States and Korea Using an Internationally Validated Nomogram

Objective:To compare disease-specific survival (DSS) between the US and Korea following R0 resection for gastric carcinoma (GC). Summary Background Data:Many studies have described decreased 5-year survival after curative gastrectomy for GC in the West compared with the East. Although clinicopathological presentations of GC are known to vary widely between Eastern and Western countries, including histology, tumor location, and stage at presentation, it remains unclear whether these factors account for differences in survival. Methods:All patients undergoing curative intent resections (R0) for GC (1995–2005) were evaluated in 2 independent, single-institution prospectively maintained databases from the US (711 patients) and Korea (1646 patients). Patients receiving neoadjuvant chemotherapy were excluded from this analysis. Patient, surgical and pathologic variables were compared. DSS was determined via multivariate analysis using prognostic variables from an internationally validated GC nomogram that estimates the probability of 5- and 9-year survival. Results:Age and body mass index were significantly higher in US patients. Location of tumors was more often proximal in the United States (39% vs. 9%, P < 0.0001) and distal in Korea (54% vs. 33%, P < 0.0001). Korean patients had more early stage tumors (42% vs. 28% stage Ia, P < 0.0001) with a higher number of lymph nodes identified (97% vs. 79%, ≥15 lymph nodes, P < 0.0001). The 5-year DSS was higher in Korea than in the United States. After multivariate analysis, applying factors used in the nomogram, DSS of Korean GC patients remained significantly better than that of US patients (HR = 1.3, 95% CI; 1.0–1.6, P = 0.008). Conclusions:This study demonstrates better survival for GC patients in Korea compared with the US as determined by multivariate analysis with a validated gastric cancer nomogram. Multiple possibilities can explain this difference.

[1]  O. Dent,et al.  Quality of life in patients undergoing treatment for chronic radiation‐induced rectal bleeding , 1998, The British journal of surgery.

[2]  C. Velde,et al.  Lymphadenectomy for gastric cancer in clinical trials: Update , 1995, World Journal of Surgery.

[3]  D. Coit,et al.  Radical surgery for gastric cancer. A review of the Japanese experience , 1989, Cancer.

[4]  F. Muscari,et al.  Risk factors for mortality and intra-abdominal morbidity after distal pancreatectomy. , 2005, Surgery.

[5]  A R Feinstein,et al.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. , 1985, The New England journal of medicine.

[6]  M. Kattan,et al.  Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Tai-xiang Wu,et al.  Interleukin-10 -1082 promoter polymorphism associated with gastric cancer among Asians. , 2008, European journal of cancer.

[8]  M. Gammon,et al.  Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. , 1998, Journal of the National Cancer Institute.

[9]  J. Yu,et al.  A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer , 2006, Journal of Gastrointestinal Surgery.

[10]  C. Sima,et al.  Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. , 2008, Journal of the American College of Surgeons.

[11]  J. Choi,et al.  Detrimental Effect of Postoperative Complications on Oncologic Efficacy of R0 Pancreatectomy in Ductal Adenocarcinoma of the Pancreas , 2009, Journal of Gastrointestinal Surgery.

[12]  W. Ajiki,et al.  Comparison of stomach cancer incidence and survival in four continents. , 2003, European journal of cancer.

[13]  C. Ji,et al.  Polymorphisms of tumor necrosis factor-alpha are associated with increased susceptibility to gastric cancer: a meta-analysis , 2008, Journal of Human Genetics.

[14]  M. Stolte,et al.  Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists , 1997, The Lancet.

[15]  A R Zinsmeister,et al.  Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. , 1993, Gastroenterology.

[16]  Cornelis J H van de Velde,et al.  Validation of a nomogram for predicting disease‐specific survival after an R0 resection for gastric carcinoma , 2005, Cancer.

[17]  Jeffrey E. Lee,et al.  Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma , 2007, Annals of surgery.

[18]  J. Lagergren,et al.  Association between Body Mass and Adenocarcinoma of the Esophagus and Gastric Cardia , 1999, Annals of Internal Medicine.

[19]  H. Brenner,et al.  Cancer survival discrepancies in developed and developing countries: comparisons between the Philippines and the United States , 2009, British Journal of Cancer.

[20]  Laura H. Tang,et al.  E-cadherin gene alterations in gastric cancers in different ethnic populations. , 2008, Ethnicity & disease.

[21]  M. Yano,et al.  Accumulation of Excess Visceral Fat Is a Risk Factor for Pancreatic Fistula Formation After Total Gastrectomy , 2009, Annals of Surgical Oncology.

[22]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[23]  A. Kristal,et al.  Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  A. Lindgren,et al.  The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia , 2000, International journal of cancer.

[25]  D. Dent.  Cancer surgery: why some survival benefits may be artefactual , 1998 .

[26]  R. Schwarz,et al.  Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease location and individual patient comorbidity. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[27]  E. Cook,et al.  Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  D. Klimstra,et al.  Lymph Node Staging in Gastric Cancer: Is Location More Important Than Number?: An Analysis of 1,038 Patients , 2000, Annals of surgery.

[29]  C. Theuer.  Asian Gastric Cancer Patients at a Southern California Comprehensive Cancer Center Are Diagnosed with Less Advanced Disease and Have Superior Stage-Stratified Survival , 2000, The American surgeon.

[30]  Siewert,et al.  Prognostic relevance of systematic lymph node dissection in gastric carcinoma , 1993, The British journal of surgery.

[31]  Limin Peng,et al.  Regression Modeling of Semicompeting Risks Data , 2007, Biometrics.

[32]  E. Bollschweiler,et al.  Is the prognosis for Japanese and German patients with gastric cancer really different? , 1993, Cancer.

[33]  J. Monereo.  [Radical surgery in gastric cancer]. , 1954, Revista clinica espanola.

[34]  M. Tez,et al.  External validation of a US-derived nomogram that predicts individual survival after gastric cancer resection , 2009, Langenbeck's Archives of Surgery.

[35]  M. Brennan,et al.  Influence of the extent of resection on survival after curative treatment of gastric carcinoma. A retrospective multivariate analysis. , 1987, Archives of surgery.

[36]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[37]  M. Kattan,et al.  Predicting Individual Survival After Gastric Cancer Resection: Validation of a U.S.-Derived Nomogram at a Single High-Volume Center in Europe , 2006, Annals of surgery.

[38]  J. Ajani,et al.  Effects of sex and racial/ethnic group on the pattern of gastric cancer localization , 2002, Gastric Cancer.